Christof Höhne, head of the EIP office in Düsseldorf, has had an article published in the European Pharmaceutical Review on the key patent challenges facing pharmaceutical companies in 2018.
His article discusses a recent German decision on second medical use claims and provides background to the debate on compulsory licences.